T. Rowe Price Associates »

Neumora Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.3M 626k 13.21
2024-06-30 $6.6M 670k 9.86
2024-03-31 $10M 753k 13.75

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Neumora Therapeutics

Softbank Group Corp
BlackRock
T. Rowe Price Investment Management
BlackRock
MIC Capital Management UK
ICONIQ Capital
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Vanguard Group
Siren
EcoR1 Capital
Geode Capital Management
Johnson & Johnson
Avidity Partners Management
OrbiMed Advisors
State Street Corporation

View all funds holding Neumora Therapeutics